NKTR looks de-risked after positive Rezpeg phase 2 data in atopic dermatitis & alopecia areata, with 80% upside and $1.1B ...

Arial, Helvetica, sans-serif; line-height: 1.6; color: #111; max-width: 980px; margin: 0 auto; padding: 20px; } ...

Arcutis Biotherapeutics (ARQT) is evolving into a specialized dermatology platform, leveraging ZORYVE's expanding indications ...

Prescription costs and over-the-counter medicines can quietly drain household budgets month after month, but according to ...

Eli Lilly has an attractive lineup and pipeline outside of its core business.

Going somewhere? Use what gets left behind to your advantage on your 2026 vacation.

Pharmacal issued a recall for Multi-symptom Treatment Cream & Skin Protectant Eczema Cream for being potentially ...

Telehealth company Hims & Hers Health Inc. has an audacious proposal for American consumers. “The rich have health care that comes to them,” says one of the company’s ads, a dizzying montage of pills, ...

A Supreme Court case heard this week could give brand-name drugmakers longer monopolies, delay generic competition, and leave patients paying higher prices. When it comes to generic medications, ...

(NEXSTAR) – A Wisconsin company is recalling a cream used to treat eczema and other conditions after it was found to be ...